Tranche Update on Electromed, Inc.'s Equity Buyback Plan announced on May 27, 2021.
February 14, 2023 at 04:11 pm EST
Share
From October 1, 2022 to December 31, 2022, the company has repurchased 800 shares, representing 0.009427% for $0.008224 million. With this, the company has completed the repurchase of 239,955 shares, representing 2.8% for $2.72 million under the buyback announced on May 27, 2021.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED, INC. 
